In addition, the UBX7-p97-UFD1/NPL4 complex, consisting of a ubiquitin-targeted ATP-dependent segregase, p97, and two heterodimeric cofactors, UBX7 and UFD1/NPL4, extracts ubiquitinated NRF2 from the KEAP1-NRF2 complex and transfers it to the 26S proteasome for its degradation [154] (Fig
T.LasseigneB
Full trial results and Plain Language Summary: nej.md/4hRGaTY In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity
Provides antioxidant protection against cellular damage
2j), corroborating the data shown in Fig
This powerful antioxidant directly participates in phase II detoxification processes, helping the liver process and eliminate toxins, medications, and metabolic waste products more effectively